09.04.2015 Views

ABSTRACTS from 16th International COnference on ... - CRRT Online

ABSTRACTS from 16th International COnference on ... - CRRT Online

ABSTRACTS from 16th International COnference on ... - CRRT Online

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

D28<br />

Extracorporeal Techniques for Sepsis 2<br />

Patrick M. H<strong>on</strong>oré MD<br />

8:00-9:30<br />

Thursday, February 16<br />

Educati<strong>on</strong>al Objectives:<br />

1)Review briefly the rati<strong>on</strong>ale of Hybrid therapy in sepsis regarding experimental issues.Special focus <strong>on</strong> Hybrid<br />

therapy regarding large bore membranes and highly adsoptive membranes.<br />

2) Describe the New Possibilities given with the New Membranes for High permeability hemofiltrati<strong>on</strong> (HPHF)<br />

that do offers to the clinician especially with the combined use of high volume hemofiltrati<strong>on</strong> (for Synergic<br />

acti<strong>on</strong> ) a new tool in order to try to effectively combat septic shock with acute kidney injury (AKI).<br />

Previous studies did show that HPHF especially with combined HVHF can removed much large quantities of<br />

mediators.<br />

3)Describe the new possibilities given with the New Membranes for Hybrid Therapies regarding High<br />

Adsorptive Hemofiltrati<strong>on</strong> doing at the same time, Endotoxin Adsorpti<strong>on</strong> and Cytokine Adsorpti<strong>on</strong>.<br />

4)Review all clinical data regarding this issue.<br />

5)Try to see which clinical situati<strong>on</strong> could fit the best with those new types of membranes.<br />

C<strong>on</strong>tent Descripti<strong>on</strong>:<br />

Clinical use day by day for bedside intensivists need to be further established.Although some data can be show<br />

about safety issues regarding the use of some membranes.<br />

A step by step approach will be needed before routine implementati<strong>on</strong>.Nevertheless, some clinical scenarios can<br />

be outlined so far.<br />

Briefly, we should describe new insides regarding the “New Active Transportati<strong>on</strong> between two Asymmetric<br />

Compartments” Hypothesis and New Insights into Rati<strong>on</strong>ale & Potential Mechanisms. Pro-mediators as well as<br />

mediators are removed at interstitial and tissue levels, following removal <str<strong>on</strong>g>from</str<strong>on</strong>g> the blood compartment, until a socalled<br />

threshold point is reached at which some pathways and cascades are stopped .At this level, the cascades<br />

are interrupted and no further harm can be d<strong>on</strong>e to the tissues.Until recently, this mechanism was taught to be a<br />

passive transportati<strong>on</strong> pathway.As said in the introducti<strong>on</strong>, effectiveness through <strong>on</strong>ly a passive transportati<strong>on</strong><br />

mechanism remains elusive.Indeed as dem<strong>on</strong>strated before and knowing that the surface of the central blood<br />

compartment (CEBC) is about 30 mÇ, which is much smaller than the surface of the capillary blood compartment<br />

(CABC)which is about 300 mÇand therefore passive transport between these two asymmetric compartments<br />

will not yield the same eliminati<strong>on</strong> rate <strong>on</strong> both sides.As a c<strong>on</strong>sequence, when a given technique is able to<br />

remove 40 % of the mediators of the CEBC side, it will <strong>on</strong>ly represents 4 % of the removal into the CABC side<br />

if the removal is <strong>on</strong>ly a passive mechanism.It is therefore easy to understand, that an other mechanism has to<br />

take place and this should be this time, an active transportati<strong>on</strong> mechanism. Previous studies did show that<br />

HPHF especially with combined HVHF can removed much large quantities of mediators.A preliminary study<br />

called the HICOSS study(High Cut-off in Septic Shock)was looking as pilot study in order to compare in 80<br />

patients with Septic Shock plus AKI. 40 patients were assigned with c<strong>on</strong>venti<strong>on</strong>al membrane and 40 patients<br />

were assigned with an hyperpermeable membrane (septex).Those patients were in septic shock plus AKI but also<br />

in multiple organ failure (MODS).The mode chosen was CVVD for 5 c<strong>on</strong>secutive days.The principal aim was to<br />

evaluate the safety regarding albumin losses (cut-off of 60 kDa) and a 50 % reducti<strong>on</strong> in catecholamine requirements.Mortality<br />

was a sec<strong>on</strong>dary end point.The results shows a excellent safety as the membrane was not loosing<br />

albumin more than a classical membrane.Nevertheless, regarding vasopressors free days as well length of ICU<br />

stay and mortality , no differences could be seen between the two groups.This may be due the fact that the mode<br />

111

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!